The document states that GPT-5.5 underwent OpenAI's full pre-deployment safety evaluation suite, including the Preparedness Framework, with targeted red-teaming specifically covering advanced cybersecurity and biology capabilities, supplemented by structured feedback from approximately 200 early-access partners.
This analysis describes what OpenAI's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision establishes the evidentiary basis for OpenAI's safety claims at deployment and identifies cybersecurity and biology as the primary dual-use capability risk domains subjected to structured adversarial testing. Organizations and regulators evaluating compliance with AI safety obligations may reference this disclosure when assessing whether the pre-deployment process meets applicable standards.
Interpretive note: The document does not disclose specific Preparedness Framework thresholds, evaluation scores, or outcomes, limiting independent assessment of the sufficiency of the described process.
The agreement establishes that GPT-5.5 was evaluated for advanced cybersecurity and biology capability risks before release, which informs the safeguard posture under which the model is made available to users. Under these terms, the described evaluation process represents the basis for the safety assurances accompanying deployment.
Cross-platform context
See how other platforms handle Preparedness Framework and Red-Teaming Scope and similar clauses.
Compare across platforms →"We subjected the model to our full suite of predeployment safety evaluations and our Preparedness Framework, including targeted red-teaming for advanced cybersecurity and biology capabilities, and collected feedback on real use cases from nearly 200 early-access partners before release.Excerpt from OpenAI's GPT-5.5 System Card
(1) REGULATORY LANDSCAPE: The explicit identification of cybersecurity and biology as red-teaming targets engages with the EU AI Act's requirements for conformity assessments of high-risk AI systems and with biosecurity-related dual-use research oversight frameworks.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision establishes the evidentiary basis for OpenAI's safety claims at deployment and identifies cybersecurity and biology as the primary dual-use capability risk domains subjected to structured adversarial testing. Organizations and regulators evaluating compliance with AI safety obligations may reference this disclosure when assessing whether the pre-deployment process meets applicable standards.
The agreement establishes that GPT-5.5 was evaluated for advanced cybersecurity and biology capability risks before release, which informs the safeguard posture under which the model is made available to users. Under these terms, the described evaluation process represents the basis for the safety assurances accompanying deployment.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by OpenAI.